Abstract
To obtain quantitative information on human metabolism of selenium, we have performed selenium speciation analysis by HPLC/ICPMS on samples of human urine from one volunteer over a 48-hour period after ingestion of selenium (1.0 mg) as sodium selenite, L-selenomethionine, or DL-selenomethionine. The three separate experiments were performed in duplicate. Normal background urine from the volunteer contained total selenium concentrations of 8–30 μg Se/L (n=22) but, depending on the chromatographic conditions, only about 30–70% could be quantified by HPLC/ICPMS. The major species in background urine were two selenosugars, namely methyl-2-acetamido-2-deoxy-1-seleno-β-D-galactopyranoside (selenosugar 1) and its deacylated analog methyl-2-amino-2-deoxy-1-seleno-β-D-galactopyranoside (selenosugar 3). Selenium was rapidly excreted after ingestion of the selenium compounds: the peak concentrations (∼250–400 μg Se/L, normalized concentrations) were recorded within 5–9 hours, and concentrations had returned to close to background levels within 48 hours, by which time 25–40% of the ingested selenium, depending on the species ingested, had been accounted for in the urine. In all experiments, the major metabolite was selenosugar 1, constituting either ∼80% of the total selenium excreted over the first 24 hours after ingestion of selenite or L-selenomethionine or ∼65% after ingestion of DL-selenomethionine. Selenite was not present at significant levels (<1 μg Se/L) in any of the samples; selenomethionine was present in only trace amounts (∼1 μg/L, equivalent to less than 0.5% of the total Se) following ingestion of L-selenomethionine, but it constituted about 20% of the excreted selenium (first 24 hours) after ingestion of DL-selenomethionine, presumably because the D form was not efficiently metabolized. Trimethylselenonium ion, a commonly reported urine metabolite, could not be detected (<1 μg/L) in the urine samples after ingestion of selenite or selenomethionine. Cytotoxicity studies on selenosugar 1 and its glucosamine isomer (selenosugar 2, methyl-2-acetamido-2-deoxy-1-seleno-β-D-glucosopyranoside) were performed with HepG2 cells derived from human hepatocarcinoma, and these showed that both compounds had low toxicity (about 1000-fold less toxic than sodium selenite). The results support earlier studies showing that selenosugar 1 is the major urinary metabolite after increased selenium intake, and they suggest that previously accepted pathways for human metabolism of selenium involving trimethylselenonium ion as the excretionary end product may need to be re-evaluated.
Similar content being viewed by others
References
Birringer M, Pilawa S, Flohe L (2002) Nat Prod Rep 19:693–718
Alaejos MS, Romero CD (1993) Clin Chem 39:2040–2052
Yang G, Ge K, Chen J, Chen X (1988) World Rev Nutr Diet 55:98–152
Klein EA, Lippman SM, Thompson IM, Goodman PJ, Albanes D, Taylor PR, Coltman C (2003) World J Urol 21:21–27
Byard JL (1969) Arch Biochem Biophys 130:556–560
Burk RF (1976) Trace elements in human health and diseases, vol 2. Academic, New York, pp 105–133
Gammelgaard B, Bendahl L (2004) J Anal Atom Spectrom 19:135–142
Kobayashi Y, Ogra Y, Ishiwata K, Takayama H, Aimi N, Suzuki KT (2002) Proc Natl Acad Sci U S A 99:15932–15936
Gammelgaard B, Madsen KG, Bjerrum J, Bendahl L, Jons O, Olsen J, Sidenius U (2003) J Anal Atom Spectrom 18:65–70
Bendahl L, Gammelgaard B (2004) J Anal Atom Spectrom 19:950–957
Cao TH, Cooney RA, Woznichak MM, May SW, Browner RF (2001) Anal Chem 73:2898–2902
Francesconi KA, Pannier F (2004) Clin Chem 50:2240–2253
Gammelgaard B, Bendahl L, Wessel Jacobsen N, Stürup S (2005) J Anal Atom Spectrom (in press)
Traar P, Belaj F, Francesconi KA (2004) Aust J Chem 57:1051–1053
Ochi T, Suzuki T, Isono H, Kaise T (2004) Toxicol Appl Pharmacol 200:64–72
Thomson CD, Burton CE, Robinson MF (1978) Br J Nutr 39:579–587
Ganther HE (1986) J Am Coll Toxicol 5:1–5
Sutton KL, de Leon CAP, Ackley KL, Sutton RMC, Stalcup AM, Caruso JA (2000) Analyst 125:281–286
Rayman MP (2004) Br J Nutr 92:557–573
Acknowledgements
We thank the Austrian Science Fund (FWF project number P 16816) for financial support, and Matthias Uray for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kuehnelt, D., Kienzl, N., Traar, P. et al. Selenium metabolites in human urine after ingestion of selenite, L-selenomethionine, or DL-selenomethionine: a quantitative case study by HPLC/ICPMS. Anal Bioanal Chem 383, 235–246 (2005). https://doi.org/10.1007/s00216-005-0007-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-005-0007-8